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Oxygen as a biological molecule
Oxygen (O2) is perhaps the single most important 
molecule for the maintenance of life on Earth. Th  e 
geological record indicates that our planet’s atmospheric 
O2 concentration has ﬂ  uctuated substantially, and this is 
thought to be involved in the evolution of a broad array 
of antioxidant defenses. Th  is important and reactive 
molecule ﬁ   rst appeared in our atmosphere over 2.2 
billion years ago, and millions of years ago may have been 
as high as 35% of the atmospheric composition. Not until 
atmospheric O2 levels had stabilized at around 21% more 
than 500 million years ago and intracellular mechanisms 
evolved to utilize O2 eﬃ     ciently and to contain its 
reactivity, however, did complex multicellular organisms 
began to proliferate.
Because O2 has a high standard oxidation–reduction 
(redox) potential, it is an ideal electron acceptor – and is 
therefore a sink for the capture of energy for intracellular 
use. Th   e reactivity of O2, however, also has a cost; O2 is a 
strong oxidizing agent that strips electrons from bio-
logical macromolecules and induces intracellular damage. 
Unless adequate defenses are present to control and 
repair the damage induced by its reactive intermediates, 
O2 toxicity supervenes. Th   is is particularly well known to 
the intensive care unit physician, as prolonged exposure 
of the human lung to more than 60% oxygen at sea level 
causes diﬀ  use acute lung injury [1].
Th  e toxicity of O2 is due to its intermediate species, 
known as reactive oxygen species (ROS), which are nor-
mally scavenged by multiple cellular antioxidant systems 
present in both prokaryotic cells and eukaryotic cells. 
Although O2’s role as an intracellular electron acceptor in 
respiration has been understood for more than 100 years 
and the cell’s main defense mechanisms against O2’s toxic 
eﬀ  ects were discovered more than 50 years ago, we are 
currently entering a new era of understanding how O2
and ROS operate as cell signal transduction mechanisms 
in order to maintain intracellular homeostasis and to 
adapt to cell stress. Th   e present review is focused on O2’s 
capacity, acting through such reactive intermediates, to 
modulate signal transduction.
Oxyg  en utilization and metabolism
Approximately 90 to 95% of the O2 consumed by the 
body is utilized by mitochondria to supply cellular energy 
through respiration and oxidative phosphorylation [2,3]. 
Oxidative phosphorylation conserves energy from the 
breakdown of carbon substrates in the foods we ingest in 
the form of ATP, which is vital for cell function. To 
generate ATP by aerobic respiration, O2 is reduced to 
water in a four-electron process without the production 
of ROS. ATP is then hydrolyzed to ADP, providing energy 
to perform basic cellular functions such as the 
maintenance of ion gradients and the opening of ion 
channels for nerve conduction, for muscle contraction, 
and for cell growth, repair, and proliferation.
Energy in the form of ATP is derived from the oxidation 
of dietary carbohydrates, lipids, and proteins. Th  e pro-
por  tion of carbohydrates, lipids, and proteins utilized to 
produce ATP is cell speciﬁ   c and organ speciﬁ  c.  For 
example, adult brain cells (in the fed state) and erythro-
cytes utilize carbohydrates, whereas the energy for 
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Molecular oxygen is obviously essential for conserving 
energy in a form useable for aerobic life; however, its 
utilization comes at a cost – the production of reactive 
oxygen species (ROS). ROS can be highly damaging to 
a range of biological macromolecules, and in the past 
the overproduction of these short-lived molecules 
in a variety of disease states was thought to be 
exclusively toxic to cells and tissues such as the lung. 
Recent basic research, however, has indicated that ROS 
production – in particular, the production of hydrogen 
peroxide – plays an important role in both intracellular 
and extracellular signal transduction that involves 
diverse functions from vascular health to host defense. 
The present review summarizes oxygen’s capacity, 
acting through its reactive intermediates, to recruit the 
enzymatic antioxidant defenses, to stimulate cell repair 
processes, and to mitigate cellular damage.
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oxida  tion [4-6]. Although O2 is necessary for aerobic ATP 
generation, ROS can be produced as a by-product of the 
nonspeciﬁ  c transfer of electrons to O2 by either mito-
chondrial electron transport proteins or by nonenzymatic 
extramitochondrial reactions. Moreover, numerous 
endo  ge  nous ROS-producing enzymes utilize molecular 
O2 for their reactions. Th  e production of ROS by some 
normal and most pathological mechanisms increases as a 
function of the oxygen concentration in the tissue, which 
can result in both direct molecular damage and inter-
ference with essential redox regulatory events as 
described later. A diagram of molecular O2 use by these 
enzyme systems and the downstream consequences – 
good and bad – is shown in Figure 1.
Because O2 and its intermediates are highly reactive, 
elegant but complex systems have evolved to allow for 
the continuous production of ATP while minimizing 
ROS production by normal metabolism. Th   e proteins of 
the respiratory complexes, for instance, only allow about 
1 to 2% of the O2 consumed by the mitochondrial electron 
transport system to generate ROS. Th  is sequence of 
oxidation–reduction reactions generates a ﬂ  ow  of 
electrons through Complexes I to IV of the electron 
transport system, which produces an electromotive force 
across the inner mitochondrial membrane used by the 
ATPase, also known as Complex V, to synthesize ATP. In 
the process, small quantities of singlet oxygen and 
superoxide anion (.O2
–) are produced primarily at 
Complex I and Complex III in proportion to the local O2 
concentration and the reduction state of the carrier. 
Although such ROS can clearly damage mitochondria 
and adjacent organelles by oxidizing DNA, proteins, and 
lipids, or by promoting the formation of adducts with 
DNA, mitochondria are protected by superoxide dis  mu-
tase (SOD2) and their own glutathione and peroxidase 
systems. Th   e small amount of .O2
– that mitochondria do 
produce is quickly converted to hydrogen peroxide 
(H2O2), some of which escapes to the cytoplasm and 
participates in intracellular signal transduction. In fact 
the majority of ROS-induced cell signaling research has 
focused on catalytic changes induced by the oxidation of 
cell signaling proteins by H2O2, which is the main focus of 
the present review.
Oxygen toxicity: reactive oxygen species 
production
As already mentioned, O2 and its intermediate forms are 
highly reactive and O2 concentrations >21% have been 
known for decades to be toxic to plants, animals, and 
bacteria [7-9]. Th   e major ROS are produced by sequential 
single electron reductions of molecular O2, including 
.O2
–, H2O2 and the hydroxyl radical (Figure 2). Small 
amounts of peroxyl, hydroperoxyl, and alkoxyl radicals 
are also produced – as is the peroxynitrite anion, 
primarily from the reaction of .O2
– with nitric oxide [10]. 
Th  ese reactive molecules are short-lived oxidants that 
react with one or more electrons on intracellular proteins, 
lipids, and DNA; if left unrepaired and unabated, these 
molecules can lead to cell death via apoptosis and/or 
necrosis. Moreover, the release of oxidized or cleaved 
macromolecules into the extracellular space may have 
speciﬁ  c and nonspeciﬁ  c proinﬂ  ammatory eﬀ  ects.
Th  e range of molecular damage produced by ROS is 
rather remarkable, and encompasses, for instance, lipid 
peroxidation and nitration, protein oxidation and protein 
nitration, protein-thiol depletion, nucleic acid hydroxy-
lation and nitration, DNA strand breakage and DNA 
adduct formation. To prevent and repair such diverse 
ROS-mediated cellular damage, a range of mechanisms 
have evolved that are upregulated during periods of 
excessive ROS generation – commonly known as oxida-
tive stress – including antioxidant and repair enzymes, 
and which, not surprisingly, are under the control of 
cellular signals generated by ROS themselves.
Although mitochondria are highly eﬃ   cient at reducing 
O2 completely to water, they are still the greatest in vivo 
source of intracellular ROS production simply because of 
the amount of O2 consumed during oxidative phosphory-
lation [11,12]. Mitochondrial ROS generation, however, 
is increased at higher oxygen pressure levels as well as by 
mitochondrial damage; for instance, by mitochon  drial 
swelling during the mitochondrial permeability transi-
tion, which uncouples oxidative phosphorylation and 
increases ROS production. Uncoupling does not, how  ever, 
always increase ROS production; indeed, the produc  tion 
of ROS may actually decrease via the expression of 
uncoupling proteins, which may relieve the electron 
escape to molecular oxygen.
Th   e extent of mitochondrial ROS generation also varies 
with the type of tissue and the level of damage to the 
mitochondria. For instance, rat heart mitochondria 
normally produce more H2O2 than liver mitochondria 
[13] and mitochondria of septic animals produce more 
H2O2 than mitochondria of healthy controls [14]. A key 
point is that the regulation of tissue oxygen pressure is a 
critical factor for the control of ROS production, and loss 
of this regulation in diseases such as sepsis increases the 
amount of oxidative tissue damage.
Prevention of oxidative damage: balancing oxygen 
utilization and the antioxidant defenses
Th   e generation of ROS under homeostatic conditions is 
balanced by antioxidant defenses within and around cells, 
which include both enzymatic and nonenzymatic mecha-
nisms. Antioxidant enzymes catalytically remove ROS, 
thereby decreasing ROS reactivity, and protect proteins 
through the use of protein chaperones, transition 
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compounds that purposely function as oxidizing or 
reducing agents to maintain intracellular redox stability.
Th  e ﬁ   rst-line antioxidant enzymes, the SODs, are a 
ubiquitous group of enzymes that eﬃ   ciently catalyze the 
dismutation of superoxide anions to H2O2. Th  ree  unique 
and highly compartmentalized mammalian superoxide 
dismutases have been characterized. SOD1, or CuZn-
SOD, was the ﬁ   rst to be discovered – a homodimer 
containing copper and zinc found almost exclusively in 
the cytoplasm. SOD2, or Mn-SOD, is targeted by a 
peptide leader sequence exclusively to the mitochondrial 
matrix, where it forms a tetramer [15]. SOD3, or EC-
SOD, the most recently characterized SOD, is a 
synthesized copper and zinc-containing tetramer with a 
signal peptide that directs it exclusively to the extra-
cellular space [16]. Th   e presence of SOD2 helps to limit 
.O2
– levels and location; within the mito  chondrial matrix, 
for instance, the enzyme’s activity increases at times of 
cellular stress [15]. Th  is isoform is required for cellular 
homeostasis, and SOD2 knockout mice die soon after 
Figure 1. Molecular oxygen use by enzyme systems leading to reactive oxygen species production and downstream consequences. 
Oxygen (O2) not only leads to superoxide anion (.O2
–) generation by mitochondria and monooxygenases, but is also required for the enzymatic 
production of the important signaling molecules nitric oxide (NO) and carbon monoxide (CO). Some oxygen-derived reactive oxygen intermediates 
such as hydrogen peroxide (H2O2) have pluripotent eff  ects in the cell that are not only detrimental, such as protein and DNA oxidation and lipid 
peroxidation, but are benefi  cial and adaptive, for instance by enhancement of the antioxidant defenses. Ask1, apoptosis-signaling kinase 1; Fe, iron; 
HIF-1, hypoxia inducible factor 1; iNOS/eNOS, inducible nitric oxide synthase/endogenous nitric oxide synthase; ONOO–, peroxynitrite anion; PI3K, 
phosphoinositide 3-kinase; SOD, superoxide dismutase.
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skeletal muscle fat accumulation, and metabolic acidosis 
[17].
Th  e product of SOD, H2O2 is usually degraded by 
peroxidases to prevent subsequent cellular damage; how-
ever, H2O2 may also function as a signaling molecule. 
Although produced in small amounts under homeostatic 
circumstances, H2O2 production may increase in 
response to cellular stresses such as inﬂ  ammation. For 
cells to maintain normal H2O2 tone, therefore, other 
antioxidant defenses have evolved – including two main 
classes of enzymes. H2O2 is converted to water and O2 by 
catalase or to water and an oxidized donor by peroxi-
dases, such as the selenium-containing glutathione per-
oxi  dases. Catalase is sequestered in mammalian cells 
within the peroxisomes, which can be clustered around 
the mitochondrial outer membrane [18,19]. Much of the 
H2O2 produced within mitochondria and diﬀ  using past 
the outer membrane is therefore converted to water and 
O2. Th  e glutathione peroxidase enzymes couple H2O2 
reduction to water with the oxidation of reduced gluta-
thione to the glutathione disulphide, which is then 
reduced back to reduced glutathione primarily by the 
activity of the pentose phosphate shunt. Glutathione 
peroxidase isoenzymes are widely distributed in cells and 
tissues, and are mostly speciﬁ  c for reduced glutathione as 
a hydrogen donor [20]. Mito  chondria and certain other 
organelles also contain other systems to detoxify ROS, 
including glutaredoxin, thio  redoxin, thioredoxin reduc  tase, 
and the peroxiredoxins.
Other important enzymes with essential antioxidant 
and signaling functions are the heme oxygenases (HO-1 
and HO-2). HO-1 is the stress-inducible isoform, also 
called HSP 32, and utilizes molecular O2 and NADPH to 
catalyze the breakdown of potentially toxic heme to 
biliverdin, releasing iron and carbon monoxide. Biliverdin 
is converted to bilirubin in the cytosol by the enzyme 
biliverdin reductase. HO-1 is ubiquitous, but levels are 
especially high in Kupﬀ  er cells of the liver, in the lung, 
and in the spleen. HO-1 knockout mice have anemia and 
tissue iron accumulation and low plasma bilirubin.
HO-1 thus functions to remove a prooxidant (heme) 
and generate an antioxidant (biliverdin), and the iron and 
carbon monoxide have important signaling roles, 
especially during cell stress. Th  e iron is initially a 
prooxidant mainly because ferrous iron can donate an 
electron to acceptor molecules – if this is H2O2, the 
hydroxyl radical is generated and causes oxidative stress. 
If ferric iron can be reduced, the cycle continues (for 
example, a superoxide-driven Fenton reaction). Ferric 
iron is not highly reactive, however, and many iron-
containing enzymes are inactive in the ferric state. HO-1 
knockout mice are therefore susceptible to inﬂ  ammation 
and hypoxia but may actually suﬀ  er less lung damage 
when exposed to 100% O2 [21], perhaps in part due to the 
recruitment of iron defenses such as ferritin. HO-1 
induc  tion, however, provides protection against ischemia–
reperfusion injury of the heart and brain, provides 
protection in severe sepsis, and plays a role in tissue 
repair and in mitochondrial biogenesis [22-24]. Approaches 
to capitalize on the beneﬁ  cial eﬀ  ects of HO-1 induction 
during periods of oxidative stress in critical illness is an 
area of active investigation.
Nonenzymatic antioxidants such as reduced gluta-
thione, vitamin C, vitamin E, and β-carotene also func-
tion to protect cells from the damaging eﬀ  ects of ROS. 
Despite a wide range of mechanisms to limit .O2
– 
production, over long periods of time ambient O2 levels 
of 21% still damage DNA, protein, and lipids. To deal 
with this molecular damage, inducible repair mechanisms 
protect the cell from increased ROS production. As 
noted earlier, however, in many instances the induction 
of these defenses actually requires oxidative modiﬁ  cation 
of speciﬁ  c cell signaling proteins in order to initiate the 
protective response.
In short, the mechanisms that limit the amount of H2O2 
and other ROS within the cell must work in a coordinated 
manner with redox-regulated signaling systems. Peroxi-
redoxins, catalase, and glutathione peroxidase are all 
capable of eliminating H2O2 eﬃ   ciently [25,26], but exactly 
how these many mechanisms are coordinated is not fully 
understood – although a deeper understanding of the 
functions of speciﬁ   c ROS detoxiﬁ   cation enzymes and 
their interactions with classical phosphorylation-based 
signal transduction systems is slowly emerging.
Intracellular signaling mechanisms from oxygen 
and reactive oxygen species (hydrogen peroxide)
Recent work has indicated that H2O2 is important as a 
signaling molecule, despite the molecule’s short bio-
logical half-life, even though many questions remain 
unanswered about how it functions. Th  e major un-
resolved issues include how H2O2 gradients or channels 
are formed and main  tained in cells and organs in order to 
regulate protein function. H2O2 is also generated at the 
plasma membrane – for instance, by the dismutation of 
super  oxide generated by the NADPH oxidases – where it 
has important roles in cell proliferation and other vital 
processes. Because H2O2 readily crosses membranes, 
some investi  gators have suggested that erythrocytes, 
which are rich in catalase, are cell-protective by func-
tioning as a sink for extracellular H2O2 [27].
Because ROS-induced intracellular signaling is complex; 
investigators have used primary and transformed cell 
lines that can be easily manipulated to investigate H2O2’s 
contribution to speciﬁ   c physiological functions. Th  e 
amount of H2O2 required to function as a signaling 
molecule in various cell lines is an area of uncertainty, 
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by the activation of many cell surface receptors, including 
transforming growth factor-1β, TNFα, granulocyte–
macrophage colony-stimulating factor, platelet-derived 
growth factor, and G-protein-coupled receptors, 
contribute to redox regulation and signal transduction 
[28-30]. Intracellular H2O2 targets speciﬁ  c proteins and 
changes their activation states. Many proteins that 
contain a deprotonated cysteine residue may be redox 
regulated and susceptible to oxidation by H2O2; most 
cysteine residues of many cytosolic proteins, however, 
are protonated due the low pH in the cytosol and 
therefore do not react with H2O2 [31,32]. Th  is  eﬀ  ect may, 
however confer some speciﬁ  city, and some proteins are 
directly redox regulated, such as ion channels, p53, and 
aconitase, either by the thiol mechanism or by changes in 
the oxidation–reduction state of iron or other transition 
metals [33]. Exposure to ROS leads to reversible 
oxidation of thiol groups of key cysteine residues in many 
downstream proteins, including transcriptional regula  tors, 
kinases, Rho and RAS GTPases, phosphatases, structural 
proteins, metabolic enzymes, and SUMO ligases.
Kinases and phosphatases
Kinases phosphorylate downstream proteins in active 
intracellular signal transduction cascades, usually after 
the stimulation of a receptor. Kinases may be activated or 
inhibited by phosphorylation, and several are known to 
be redox regulated, including prosurvival and pro-
apoptotic kinases. For instance, H2O2 indirectly activates 
the prosurvival kinase Akt/PKB [34]. Akt appears to be 
necessary for host protection against multiorgan 
dysfunction from sepsis. Another kinase – apoptosis-
signaling kinase-1, a member of the mitogen-activated 
protein kinase kinase kinase family – activates the p38 
and the JNK pathways by directly phosphorylating and 
activating SEK1 (MKK4)/MKK7) and MKK3/MKK6 
[35,36]. Apoptosis-signaling kinase-1 is activated in 
response to cytotoxic stress and under the presence of 
H2O2 induced by TNFα in HEK293 cells [37,38]. Th  is 
kinase is also likely to play a role during sepsis, but how 
H2O2 manages to stimulate one kinase that is prosurvival 
versus one that results in cell death is an area of active 
investigation. Although understanding the nature of 
redox-based control of kinase activity is in its early stages 
and how these controls are aﬀ   ected during times of 
severe multisystem stress such as sepsis or trauma is just 
emerging, it is clear that excessive and nonspeciﬁ  c 
production of H2O2 during periods of oxidative stress 
interferes with speciﬁ  city of redox regulation. Not only 
are some kinases redox regulated, but their dephos-
phorylating protein counterparts (phosphatases) may 
become inactivated in response to increased intracellular 
H2O2. Phosphatases often de-activate speciﬁ  c 
phospho  proteins that have been acted on by a kinase. For 
instance, protein tyrosine phosphatase-1B becomes 
inactivated in A431 human epidermoid carcinoma cells 
in response to epidermal growth factor-induced H2O2 
production [39]. Insulin-induced H2O2 production also 
inactivates protein tyrosine phosphatase-1B [40]. Platelet-
derived growth factor has been shown to induce oxidation 
from intra  cellular H2O2 and to inhibit the SH2 domain-
containing protein tyrosine phosphatase SHP-2 in Rat-1 
cells [41]. Phosphatase and tensin homolog is also 
regulated by H2O2 [42,43]. As a general rule, phosphatase 
inactivation leads to unopposed activity of the reciprocal 
kinase; for example, phosphoinositide 3-kinase that 
activates Akt/PKB, a ubiquitous prosurvival kinase. Th  e 
functional requirements for these proteins during times of 
critical illness are an area of active investigation.
Transcription factors
Not only does H2O2 regulate certain intracellular kinase 
and phosphatase pathways, it also interacts with speciﬁ  c 
redox-responsive nuclear transcription factors, co-
activators, and repressors. Transcription factors typically 
become activated in response to signaling cascades 
activated both by membrane-bound receptors and by 
intracellular mechanisms. Transcriptional activation of a 
broad range of gene families are involved in cell survival, 
cell proliferation, antioxidant defense upregulation, DNA 
repair mechanisms, control of protein synthesis, and 
regulation of mitochondrial biogenesis. Among the 
transcription factors known to be activated in a redox-
dependent manner are Sp1, the glucocorticoid receptor, 
Egr1, p53, NF-κB, NF-E2-related factor 2 (Nfe2l2 or 
Nrf2), hypoxia inducible factor-1α, and nuclear respira-
tory factor-1. Hypoxia inducible factor-1α is a redox-
sensitive transcription factor that provides an emergency 
survival response during severe hypoxic and inﬂ  am  ma-
tory states. Several excellent reviews discuss the impor-
tance of these transcription factors and their downstream 
target genes [44,45]. NF-κB activation and Nrf2 (Nfe2l2) 
activa  tion are also of particular importance in diseases 
that aﬀ  ect critically ill patients.
NF-κB is bound in the cytoplasm to IκB in its inactive 
state [46]. Stimuli that activate NF-κB induce the proteo-
somal degradation of IκB, allowing NF-κB to translocate 
to the nucleus and bind to κB motifs in the promoter 
region of many genes, including TNFα and inducible 
nitric oxide synthase (NOS2). H2O2 clearly modulates the 
function of NF-κB; however, whether its eﬀ  ects  are 
inhibitory or activating appear to be cell-type speciﬁ  c 
[47]. H2O2 has been reported to increase the nuclear 
trans  location of NF-κB [48,49], but other studies have 
shown the opposite eﬀ  ect [50]. Although NF-κB regula-
tion by ROS is of signiﬁ  cant importance during inﬂ  am-
ma  tory states, recent work on other redox-regulated 
Bartz and Piantadosi Critical Care 2010, 14:234 
http://ccforum.com/content/14/5/234
Page 5 of 9transcription factors such as Nrf2 suggests that H2O2 has 
pluripotent eﬀ  ects.
Nrf2-dependent genes are critical for the maintenance 
of cellular redox homeostasis. Th   is transcription factor is 
constitutively expressed in the cytoplasm and is regulated 
by ubiquitinylation under the dynamic control of kelch-
like ECH-associating protein-1 [44,51,52]. In response to 
oxidative or electrophilic stress, kelch-like ECH-associat-
ing protein-1 is oxidized by H2O2. Th  is event interferes 
with Nrf2 ubiquitinylation and its disposal by the 
proteasome, which allows Nrf2 to accumulate in the 
nucleus. Nuclear Nrf2 binds to the promoters of genes 
containing the antioxidant response element consensus 
sequence [53]. Th   ese genes include hepatic drug-
metabolizing enzymes (cytochrome P450 isoforms) and 
many inducible antioxidant enzymes such as glutathione 
peroxidase, thioredoxin reductase, and peroxyredoxin-1. 
Nrf2 also induces HO-1, NAD(P)H quinone reductase-1, 
and γ-glutamyl cysteine ligase, which help regulate the 
intracellular redox state [54-57]. A simple schematic of 
Nrf2 response to mitochondrial H2O2 production is 
provided in Figure 3. Recent work suggests that Nrf2 
transcriptional control plays a signiﬁ  cant role in diseases 
associated with inﬂ  ammatory stress [58,59].
Oxidative stress and disease
In the healthy body, the ROS production and clearance 
rates are well balanced. Exogenous sources of oxidants 
and certain disease states can shift this balance by 
increasing the amount of ROS produced without 
adequate detoxiﬁ  cation. For example, unchecked oxida-
tive stress contributes to the pathogenesis of diabetes and 
its complications [60-62]. Neurodegenerative diseases, 
cancer, and aging are all associated with increased rates 
of ROS generation. Diseases in which acute or chronic 
inﬂ  ammation is a signiﬁ  cant component lead to excess 
extracellular ROS production that may tip the oxidant–
antioxidant balance towards acute and/or progressive 
organ damage, and nonspeciﬁ  c ROS production inter-
feres with the normal signals generated by ROS. On the 
other hand, exuberant ROS production in phagocytic 
cells is critical for protection against microorganisms. 
Th  e neutrophil kills bacteria through the induction of 
NADPH oxidase, which produces a burst of superoxide 
(oxidative burst). Recent work has also suggested that an 
H2O2 gradient is necessary for adequate wound healing 
(for example, in zebra ﬁ  sh), but the extent to which such 
gradients are necessary for mammalian wound healing is 
still being explored [63].
Figure 3. Schematic of Nrf2 response to mitochondrial hydrogen peroxide production. Hydrogen peroxide (H2O2)-based molecular signal 
transduction involving the constitutive Nrf2 transcription factor, which is normally targeted for ubiquitination and degradation (step 1). Various 
oxidative and electrophilic stresses can stabilize Nrf2 by the oxidation of the kelch-like ECH-associating protein-1 (Keap1) adaptor molecule, 
allowing free Nrf2 to translocate to the nucleus. The diagram indicates the role of oxidative damage and increased mitochondrial H2O2 production 
(step 2) in the stabilization of Nrf2 (step 3), and activation of genes that contain the antioxidant response element (ARE) consensus sequence – in 
this case, superoxide dismutase (SOD2) (step 4).
Nrf2
Oxidation
Electrophiles
Stabilization
Keap1
Ubiquitination and degradation
ARE
Nucleus Cytoplasm Mitochondrion
1 3
SOD2
SOD2
4
H2O2
Oxidative 
 Damage
2
Nrf2
Nrf2 Nrf2 Keap1
Oxidation
Nrf2
Bartz and Piantadosi Critical Care 2010, 14:234 
http://ccforum.com/content/14/5/234
Page 6 of 9Oxidative repair (cell protection and proliferation): 
adaptation, conditioning, and hormesis
As mentioned earlier, not all oxidative stress is 
detrimental to cell survival; in fact, optimal health may 
require a certain amount of oxidative stress. Th  e best 
example is arguably exercise, which induces ROS produc-
tion followed by the coordinated upregulation of speciﬁ  c 
antioxidant enzymes, such as SOD2. It has been known 
for years that exercise induces ROS production beyond 
basal levels, although the exact rates, species, and 
quantities are unknown. Moreover, skeletal muscle ROS 
production during exercise aﬀ  ects organs other than the 
muscles, including the liver, by unknown but probably 
indirect mechanisms [64].
Th   e idea that exposure to a small dose of a dangerous 
substance can induce a favorable biological response, 
long known as hormesis, has been applied to the 
presumed positive eﬀ  ects of H2O2 generated by exercise. 
Increased skeletal muscle contractile activity has been 
shown to produce superoxide, nitric oxide, hydrogen 
peroxide, hydroxyl radical, and peroxynitrite [65-69]. It 
was once believed that skeletal muscle mitochondria 
were the sole source of intracellular ROS during exercise 
[70,71]; however, other sources may derive from the 
sarcoplasmic reticulum, plasma membrane, or transverse 
tubules [72,73]. Th   e stresses of muscle contraction during 
exercise that generates ROS are followed by the 
upregulation of catalase, protective protein thiols and the 
SODs [74]. H2O2 diﬀ  using across membranes may result 
in protein/lipid oxidation of nearby cells during exercise 
[75], but the upregulation of the antioxidant enzymes as 
well as the redox regulation of mitochondrial biogenesis 
is probably responsible for many of the beneﬁ  ts seen with 
exercise training [76-78]. Indeed, the administration of 
large doses of low-molecular-weight antioxidants before 
exercise interferes with mitochondrial biogenesis in 
human subjects [79].
Th   ese and similar observations in other model systems 
oﬀ  er an explanation for why blanket antioxidant supple-
mentation is not the therapeutic panacea that was once 
hoped. A better understanding of how these molecular 
pathways are regulated will hopefully lead to new targets 
to induce intracellular protection and repair pathways 
during relevant critical disease states.
Conclusions
Oxygen is fundamental to the aerobic processes of 
eukaryotic life. Oxygen is consumed within the mito-
chon  dria to produce ATP, which is hydrolyzed to ADP to 
provide energy for all intracellular homeostatic and work 
functions. Because of oxygen’s high chemical reactivity, 
however, advanced life-forms have had to evolve eﬀ  ective 
mechanisms to limit the biologically-damaging eﬀ  ects of 
O2 as well as the ability to utilize its intermediates to 
support cell signaling and damage control during health 
and disease. In particular, H2O2 has emerged as an 
important signaling molecule involved in the induction 
of the antioxidant defenses, cell repair mechanisms, and 
cell proliferation. Understanding how H2O2 and other 
ROS are produced, contained, and targeted will open up 
new avenues of understanding and should lead to novel 
interventional antioxidant strategies for use in health and 
disease.
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